美国 · SEC FORM 4
Fulgent Genetics, Inc.
FLGT · Nasdaq · CIK 0001674930 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
25 同一窗口内观察到的 Form 4 交易行
8 sales · 17 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-03-05 · Kim Paul.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,238,210
- 上期报告
- 2,318,058
- 日均成交量
- 311,711
- 回补天数
- 7.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-03-05 | Kim Paul | 买入 (P) | Common Stock | 100,000 | USD 15.96 | USD 1,596,000 | SEC 申报 ↗ |
Form 4 申报证据
87 transaction lines in the latest 365-day window; 492 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Xie Jian | 卖出 (S) | Common Stock | 2,127 | USD 19.66 | USD 41,817 | SEC 申报 ↗ |
| 2026-09-02 | Gao Hanlin | 卖出 (S) | Common Stock | 1,673 | USD 19.66 | USD 32,891 | SEC 申报 ↗ |
| 2026-09-01 | Kim Paul | 代扣税 (F) | Common Stock | 2,087 | USD 19.59 | USD 40,884 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Xie Jian | 卖出 (S) | Common Stock | 2,127 | USD 19.66 | USD 41,817 | SEC 申报 ↗ |
| 2026-09-02 | Gao Hanlin | 卖出 (S) | Common Stock | 1,673 | USD 19.66 | USD 32,891 | SEC 申报 ↗ |
| 2026-09-01 | Kim Paul | 代扣税 (F) | Common Stock | 2,087 | USD 19.59 | USD 40,884 | SEC 申报 ↗ |
| 2026-09-01 | Hsieh Ming | 代扣税 (F) | Common Stock | 4,392 | USD 19.59 | USD 86,039 | SEC 申报 ↗ |
| 2026-08-27 | Xie Jian | 卖出 (S) | Common Stock | 1,193 | USD 19.91 | USD 23,753 | SEC 申报 ↗ |
| 2026-08-27 | Gao Hanlin | 卖出 (S) | Common Stock | 939 | USD 19.91 | USD 18,695 | SEC 申报 ↗ |
| 2026-08-26 | Kim Paul | 代扣税 (F) | Common Stock | 1,168 | USD 19.81 | USD 23,138 | SEC 申报 ↗ |
| 2026-08-26 | Hsieh Ming | 代扣税 (F) | Common Stock | 2,949 | USD 19.81 | USD 58,420 | SEC 申报 ↗ |
| 2026-07-26 | Xie Jian | 代扣税 (F) | Common Stock | 4,361 | USD 19.67 | USD 85,781 | SEC 申报 ↗ |
| 2026-07-26 | Kim Paul | 代扣税 (F) | Common Stock | 2,747 | USD 19.67 | USD 54,033 | SEC 申报 ↗ |
| 2026-07-26 | Gao Hanlin | 代扣税 (F) | Common Stock | 1,645 | USD 19.67 | USD 32,357 | SEC 申报 ↗ |
| 2026-06-02 | Xie Jian | 卖出 (S) | Common Stock | 2,146 | USD 17.89 | USD 38,392 | SEC 申报 ↗ |
| 2026-06-02 | Gao Hanlin | 卖出 (S) | Common Stock | 1,688 | USD 17.89 | USD 30,198 | SEC 申报 ↗ |
| 2026-06-01 | Kim Paul | 代扣税 (F) | Common Stock | 2,087 | USD 18.09 | USD 37,754 | SEC 申报 ↗ |
| 2026-06-01 | Hsieh Ming | 代扣税 (F) | Common Stock | 4,392 | USD 18.09 | USD 79,451 | SEC 申报 ↗ |
| 2026-05-27 | Xie Jian | 卖出 (S) | Common Stock | 1,201 | USD 17.60 | USD 21,138 | SEC 申报 ↗ |
| 2026-05-27 | Gao Hanlin | 卖出 (S) | Common Stock | 945 | USD 17.60 | USD 16,632 | SEC 申报 ↗ |
| 2026-05-26 | Kim Paul | 代扣税 (F) | Common Stock | 1,168 | USD 17.67 | USD 20,639 | SEC 申报 ↗ |
| 2026-05-26 | Hsieh Ming | 代扣税 (F) | Common Stock | 2,949 | USD 17.67 | USD 52,109 | SEC 申报 ↗ |
| 2026-05-14 | Nohaile Michael | 奖励／授予 (A) | Common Stock | 5,558 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | GROVES REGINA E | 奖励／授予 (A) | Common Stock | 11,117 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Dong Linda | 奖励／授予 (A) | Common Stock | 11,117 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-26 | Xie Jian | 代扣税 (F) | Common Stock | 4,361 | USD 16.31 | USD 71,128 | SEC 申报 ↗ |
| 2026-04-26 | Kim Paul | 代扣税 (F) | Common Stock | 2,747 | USD 16.31 | USD 44,804 | SEC 申报 ↗ |
| 2026-04-26 | Gao Hanlin | 代扣税 (F) | Common Stock | 1,645 | USD 16.31 | USD 26,830 | SEC 申报 ↗ |
| 2026-03-01 | Xie Jian | 代扣税 (F) | Common Stock | 9,226 | USD 15.33 | USD 141,435 | SEC 申报 ↗ |
| 2026-03-01 | Kim Paul | 代扣税 (F) | Common Stock | 9,480 | USD 15.33 | USD 145,328 | SEC 申报 ↗ |
| 2026-03-01 | Hsieh Ming | 代扣税 (F) | Common Stock | 17,566 | USD 15.33 | USD 269,287 | SEC 申报 ↗ |
| 2026-03-01 | Gao Hanlin | 代扣税 (F) | Common Stock | 7,428 | USD 15.33 | USD 113,871 | SEC 申报 ↗ |
| 2026-02-26 | Xie Jian | 代扣税 (F) | Common Stock | 1,140 | USD 24.76 | USD 28,226 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | FLGT |
| CIK | 0001674930 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 492 transaction lines from 2020-02-10 to 2026-09-02 1 P purchase lines · 151 S sale lines · 340 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.